Date:1/22/2013

, Global, Key Company Revenue ($m), 2011 17Table 4: Peripheral Vascular Devices Market, Germany, Number of Procedures ('000), 2005-2008 21Table 5: Stent Grafts Market, Global, Revenue ($m), 2004-2011 26Table 6: Stent Grafts Market, Global, Revenue ($m), 2011-2018 27Table 7: Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011 28Table 8: Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018 29Table 9: PTA Balloons Market, Global, Revenue ($m), 2004-2011 30Table 10: PTA Balloons Market, Global, Revenue ($m), 2011-2018 31Table 11: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011 32Table 12: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018 33Table 13: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011 34Table 14: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018 35Table 15: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011 36Table 16: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018 37Table 17: Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011 38Table 18: Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018 39Table 19: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2004-2011 40Table 20: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018 41Table 21: Peripheral Vascular Devices Market, Global, Cross-country Analysis, CAGR (%), 2004-2018 42Table 22: Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011 44Table 23: Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018 45Table 24: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2004-2011 47Table 25: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2011-2018 48Table 26: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2004-2011 49Table 27: Peripheral Vas
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine technology :

1. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
2. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
3. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Global Peripheral Vascular Devices Market 2011-2015
5. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
6. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
7. European Markets for Peripheral Vascular Devices 2012
8. European Market for Peripheral Vascular Devices
9. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
10. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
11. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications